Here, we propose that signalling regulated by DGK could provide a key role in the mechanisms of action for VPA (Fig. 7), in addition to other proposed therapeutic compounds that could provide treatments for both epilepsy and bipolar disorder. This evidence concerns the gene DGKE and bipolar disorder.